The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Dual Inhibition of β-Adrenergic and Angiotensin II Receptors by a Single Antagonist: A Functional Role for Receptor–Receptor Interaction In Vivo
Open accessAbstract
Background— Although the renin–angiotensin and the β-adrenergic systems are interrelated, a direct interaction between β-adrenergic receptors (βARs) and angiotensin II type 1 receptors (AT 1 Rs) has not been identified. Methods and Results— Here, we provide evidence for a functional and physiological interaction between 2 G protein–coupled receptors: the βAR and the AT 1 R. Selective blockade of βARs in mouse cardiomyocytes inhibits angiotensin-induced contractility with an IC 50 that is similar to its inhibition of isoproterenol-mediated contractility. Furthermore, administration of the angiotensin receptor blocker valsartan to intact mice results in a significant reduction in the maximal response to catecholamine-induced elevation of heart rate. The mechanism for this transinhibitory effect of β-blockers and angiotensin receptor blockers is through receptor–G protein uncoupling; ie, β-blockers interfere with AT 1 R-G q coupling, and valsartan interferes with βAR-G s coupling. Finally, we demonstrate that AT 1 Rs and βARs form constitutive complexes that are not affected by ligand stimulation. As a result of these interactions, a single receptor antagonist effectively blocks downstream signaling and trafficking of both receptors simultaneously. Conclusions— We show that direct interactions between βARs and AT 1 Rs may have profound consequences on the overall response to drugs that antagonize these receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,121
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
(1999) · The Lancet · doi:10.1016/s0140-6736(98)11181-9 · Cited by 4,929
Swedberg, K., & Kjekshus, J. (1988) · The American Journal of Cardiology · doi:10.1016/s0002-9149(88)80087-0 · Cited by 3,762
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
Cohn, J. N., & Tognoni, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010713 · Cited by 3,108
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., Fowler, M. B., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Castaigne, A., Roecker, E. B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442201 · Cited by 3,093
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., & Fowler, M. B. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00477-9 · Cited by 1,661
G-protein-coupled receptor heterodimerization modulates receptor function
Jordan, B. A., & Devi, L. A. (1999) · Nature · doi:10.1038/21441 · Cited by 1,166
Seven-transmembrane-spanning receptors and heart function
Rockman, H. A., Koch, W. J., & Lefkowitz, R. J. (2002) · Nature · doi:10.1038/415206a · Cited by 938
Self-citationOakley, R. H., Laporte, S. A., Holt, J. A., Caron, M. G., & Barak, L. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910348199 · Cited by 882
Ungerer, M., Böhm, M., Elce, J. S., Erdmann, E., & Lohse, M. J. (1993) · Circulation · doi:10.1161/01.cir.87.2.454 · Cited by 878
Desensitization of G-protein-coupled Receptors
Xiao, Z., Yao, Y., Long, Y., & Devreotes, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1440 · Cited by 521
AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration
AbdAlla, S., Lother, H., & Quitterer, U. (2000) · Nature · doi:10.1038/35024095 · Cited by 503
Increased AT1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness
AbdAlla, S., Lother, H., el Massiery, A., & Quitterer, U. (2001) · Nature Medicine · doi:10.1038/nm0901-1003 · Cited by 496
Angiotensin II Type 1 Receptor Blockers
Burnier, M. (2001) · Circulation · doi:10.1161/01.cir.103.6.904 · Cited by 485
Esposito, G., Rapacciuolo, A., Naga Prasad, S. V., Takaoka, H., Thomas, S. A., Koch, W. J., & Rockman, H. A. (2002) · Circulation · doi:10.1161/hc0102.101365 · Cited by 377
Self-citationJordan, B. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011384898 · Cited by 328
Terrillon, S., Durroux, T., Mouillac, B., Breit, A., Ayoub, M. A., Taulan, M., Jockers, R., Barberis, C., & Bouvier, M. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0222 · Cited by 322
G-protein-coupled receptor dimerization: modulation of receptor function
Rios, C. D., Jordan, B. A., Gomes, I., & Devi, L. A. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00160-7 · Cited by 309
Mechanism of Action of Beta-Blocking Agents in Heart Failure
Bristow, M. R. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00846-1 · Cited by 259
How activated receptors couple to G proteins
Hamm, H. E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011099798 · Cited by 203
Naga Prasad, S. V., Barak, L. S., Rapacciuolo, A., Caron, M. G., & Rockman, H. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102376200 · Cited by 179
Self-citationWhy does the myocardium fail? Insights from basic science
Bristow, M. R. (1998) · The Lancet · doi:10.1016/s0140-6736(98)90311-7 · Cited by 169
Rockman, H. A., Choi, D.-J., Akhter, S. A., Jaber, M., Giros, B., Lefkowitz, R. J., Caron, M. G., & Koch, W. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18180 · Cited by 165
Self-citationBarki‐Harrington, L., Bookout, A. L., Wang, G., Lamb, M. E., Leeb-Lundberg, L. M. F., & Daaka, Y. (2003) · Biochemical Journal · doi:10.1042/bj20021708 · Cited by 74
Self-citationSullivan, R. J., Châteauneuf, A., Coulombe, N., Kolakowski, L. F., Johnson, M. P., Hébert, T. E., Éthier, N., Belley, M. L., Metters, K. M., Abramovitz, M., et al. (2000) · PubMed · Cited by 49
Selective Inhibition of Heterotrimeric GsSignaling
Feldman, D. S., Zamah, A. M., Pierce, K. L., Miller, W. E., Kelly, F. L., Rapacciuolo, A., Rockman, H. A., Koch, W. J., & Luttrell, L. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204753200 · Cited by 38
Self-citation
Cited by
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Mehta, P. K., & Griendling, K. K. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00287.2006 · Cited by 1,924
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,095
Roles of G‐protein‐coupled receptor dimerization: From ontogeny to signalling regulation
Terrillon, S., & Bouvier, M. (2004) · EMBO reports · doi:10.1038/sj.embor.7400052 · Cited by 683
Hunyady, L., & Catt, K. J. (2006) · Molecular Endocrinology · doi:10.1210/me.2004-0536 · Cited by 541
G Protein-Coupled Receptor Dimerization: Function and Ligand Pharmacology
Milligan, G. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.000497 · Cited by 474
Metadata
- Authors
- Barki-Harrington, L., Luttrell, L. M., & Rockman, H. A.
- Venue
- Circulation
- Published
- 2003-09-30
- Volume
- 108
- Issue
- 13
- Pages
- 1611-1618
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2142789746
- Cited by
- 252
- References
- 27
- FWCI
- 5.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.